Date: 2015-09-15
Type of information: Nomination
Compound:
Company: Kite Pharma (USA - CA)
Therapeutic area: Cancer - Oncology - Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 15, 2015, Kite Pharma announced that Dr. Franz B. Humer , the former Chairman and Chief Executive of Roche Holding Ltd., has been appointed to the Company's Board of Directors. Dr. Humer began his career in the pharmaceutical industry in 1973, joining Schering Plough Corporation where he held various General Management positions in Latin America and Europe . After leaving Schering Plough , he joined the Board of Glaxo Holdings plc and progressed to be responsible for research, business development, manufacturing, commercial strategy, and all non-US operations for 13 years. Subsequent to this, Dr. Humer served as Head of Pharmaceuticals and then as Chief Operating Officer of F. Hoffmann-La Roche Ltd. , prior to his taking the helm as CEO at Roche Group (1998-2001) and then Chairman and CEO (2001-2008). His tenure as Chairman of Roche Holding Ltd. extended from 2008 to 2014. Dr. Humer serves as Chairman of the Board of Directors of the International Centre for Missing and Exploited Children and the Humer Foundation . He is also Chairman of Diageo plc, an Independent Director with Citigroup Inc., Chugai Pharmaceuticals Ltd. ( Japan ), Bial Pharmaceuticals ( Portugal ), WISeKey ( Cyber Security Company , Switzerland ) and a member of the International Advisory Board of Allianz SE .
Financial terms:
Latest news:
